Published in Gastroenterology on May 01, 2009
Metagenomic biomarker discovery and explanation. Genome Biol (2011) 11.29
The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol (2011) 2.26
Metagenomic analysis of the viromes of three North American bat species: viral diversity among different bat species that share a common habitat. J Virol (2010) 2.18
Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc Natl Acad Sci U S A (2010) 2.10
Small intestinal bacterial overgrowth syndrome. World J Gastroenterol (2010) 1.99
Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing. DNA Res (2013) 1.78
Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther (2010) 1.73
Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr (2011) 1.63
An update on the use and investigation of probiotics in health and disease. Gut (2013) 1.62
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol (2010) 1.58
Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS One (2012) 1.50
Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri. MBio (2015) 1.45
Probiotics-host communication: Modulation of signaling pathways in the intestine. Gut Microbes (2011) 1.38
Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap Adv Gastroenterol (2013) 1.35
Drosophila melanogaster as a model for human intestinal infection and pathology. Dis Model Mech (2011) 1.29
Insights from characterizing extinct human gut microbiomes. PLoS One (2012) 1.29
Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps. Gut Microbes (2012) 1.23
Assessing gut microbial diversity from feces and rectal mucosa. Microb Ecol (2010) 1.21
Probiotics, enteric and diarrheal diseases, and global health. Gastroenterology (2010) 1.16
The immune system in irritable bowel syndrome. J Neurogastroenterol Motil (2011) 1.16
'Gut health': a new objective in medicine? BMC Med (2011) 1.15
The struggle within: microbial influences on colorectal cancer. Inflamm Bowel Dis (2011) 1.15
Compositional and functional features of the gastrointestinal microbiome and their effects on human health. Gastroenterology (2014) 1.14
Gut microbiota and probiotics in colon tumorigenesis. Cancer Lett (2011) 1.12
Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine. FASEB J (2012) 1.10
Diet and the development of the human intestinal microbiome. Front Microbiol (2014) 1.10
The gut microbiota and irritable bowel syndrome: friend or foe? Int J Inflam (2012) 1.09
Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients (2013) 1.08
Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics (2011) 1.08
Colonic mucosal DNA methylation, immune response, and microbiome patterns in Toll-like receptor 2-knockout mice. FASEB J (2011) 1.05
Interactions in the microbiome: communities of organisms and communities of genes. FEMS Microbiol Rev (2013) 1.05
Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings. Appl Environ Microbiol (2011) 1.01
Evaluation of the routine use of amoxicillin as part of the home-based treatment of severe acute malnutrition. Trop Med Int Health (2010) 1.01
Role of the enteric microbiota in intestinal homeostasis and inflammation. Free Radic Biol Med (2013) 0.98
Prostate cancer and the influence of dietary factors and supplements: a systematic review. Nutr Metab (Lond) (2014) 0.98
Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut Microbes (2013) 0.97
Extracellular matrix structure governs invasion resistance in bacterial biofilms. ISME J (2015) 0.97
Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis. Clin Exp Immunol (2010) 0.96
Comparative proteomic analysis of Lactobacillus plantarum for the identification of key proteins in bile tolerance. BMC Microbiol (2011) 0.96
Host response to probiotics determined by nutritional status of rotavirus-infected neonatal mice. J Pediatr Gastroenterol Nutr (2012) 0.93
Hospitalization Type and Subsequent Severe Sepsis. Am J Respir Crit Care Med (2015) 0.93
The human microbiome in hematopoiesis and hematologic disorders. Blood (2015) 0.91
The newest "omics"--metagenomics and metabolomics--enter the battle against the neglected tropical diseases. PLoS Negl Trop Dis (2015) 0.90
The remarkable capacity for gut microbial and host interactions. Gut Microbes (2011) 0.90
Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open (2014) 0.90
Impact of the metabolic activity of Streptococcus thermophilus on the colon epithelium of gnotobiotic rats. J Biol Chem (2011) 0.88
Relationship between intestinal microbiota and colorectal cancer. World J Gastrointest Oncol (2015) 0.88
A randomised clinical trial (RCT) of a symbiotic mixture in patients with irritable bowel syndrome (IBS): effects on symptoms, colonic transit and quality of life. Int J Colorectal Dis (2012) 0.87
Cyclopropane fatty acid synthase mutants of probiotic human-derived Lactobacillus reuteri are defective in TNF inhibition. Gut Microbes (2011) 0.87
The Efficacy of Saccharomyces boulardii CNCM I-745 in Addition to Standard Helicobacter pylori Eradication Treatment in Children. Pediatr Gastroenterol Hepatol Nutr (2015) 0.87
Replenishing our defensive microbes. Bioessays (2013) 0.87
Lactobacillus reuteri promotes Helicobacter hepaticus-associated typhlocolitis in gnotobiotic B6.129P2-IL-10(tm1Cgn) (IL-10(-/-) ) mice. Immunology (2011) 0.86
Characterization and in vitro properties of oral lactobacilli in breastfed infants. BMC Microbiol (2013) 0.85
Biofunctionalization of silicone polymers using poly(amidoamine) dendrimers and a mannose derivative for prolonged interference against pathogen colonization. Biomaterials (2011) 0.84
Antibiotics increase gut metabolism and antioxidant proteins and decrease acute phase response and necrotizing enterocolitis in preterm neonates. PLoS One (2012) 0.81
Microbiota biodiversity in inflammatory bowel disease. Ital J Pediatr (2014) 0.81
Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial. PLoS One (2015) 0.81
Bacterial protein AvrA stabilizes intestinal epithelial tight junctions via blockage of the C-Jun N-terminal kinase pathway. Tissue Barriers (2015) 0.80
How the microbiota shapes rheumatic diseases. Nat Rev Rheumatol (2016) 0.80
Bioengineered probiotics, a strategic approach to control enteric infections. Bioengineered (2013) 0.80
Taxonomic and functional diversity of cultured seed associated microbes of the cucurbit family. BMC Microbiol (2016) 0.79
Genomic medicine in gastroenterology: A new approach or a new specialty? World J Gastroenterol (2015) 0.79
The Fecal Microbiome in Pediatric Patients With Short Bowel Syndrome. JPEN J Parenter Enteral Nutr (2015) 0.79
Recent advances in small bowel diseases: Part I. World J Gastroenterol (2012) 0.79
Decreased plasma myeloperoxidase associated with probiotic therapy in autistic children. Clin Med Insights Pediatr (2015) 0.78
Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate. World J Gastroenterol (2016) 0.78
Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation. Curr Hematol Malig Rep (2016) 0.78
Treating Obesity and Metabolic Syndrome with Fecal Microbiota Transplantation. Yale J Biol Med (2016) 0.78
Immunomodulation by gut microbiota: role of Toll-like receptor expressed by T cells. J Immunol Res (2014) 0.78
Heritable components of the human fecal microbiome are associated with visceral fat. Genome Biol (2016) 0.77
Catheterization of intestinal loops in ruminants does not adversely affect loop function. Comp Med (2010) 0.77
Protective and pro-inflammatory roles of intestinal bacteria. Pathophysiology (2016) 0.77
Diet and the Gut. Middle East J Dig Dis (2016) 0.76
Metabolic disease puts up a fight: microbes, metabolism and medications. Nat Med (2013) 0.76
Active hexose-correlated compound and Bifidobacterium longum BB536 exert symbiotic effects in experimental colitis. Eur J Nutr (2012) 0.76
Mechanisms of Cross-talk between the Diet, the Intestinal Microbiome, and the Undernourished Host. Gut Microbes (2016) 0.76
A Bayesian approach to inferring the phylogenetic structure of communities from metagenomic data. Genetics (2014) 0.76
Microbes can help explain the evolution of host altruism. Nat Commun (2017) 0.75
Prolonged antibiotic use induces intestinal injury in mice that is repaired after removing antibiotic pressure: implications for empiric antibiotic therapy. Metabolomics (2014) 0.75
Effects of Dietary Yogurt on the Healthy Human Gastrointestinal (GI) Microbiome. Microorganisms (2017) 0.75
Navigating social and ethical challenges of biobanking for human microbiome research. BMC Med Ethics (2017) 0.75
The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control (2017) 0.75
Effects of Liver Resection on Hepatic Short-Chain Fatty Acid Metabolism in Humans. PLoS One (2016) 0.75
Effect of Bifidobacterium breve on the Intestinal Microbiota of Coeliac Children on a Gluten Free Diet: A Pilot Study. Nutrients (2016) 0.75
Microbial lysate upregulates host oxytocin. Brain Behav Immun (2016) 0.75
Modulation of Multiple Sclerosis and Its Animal Model Experimental Autoimmune Encephalomyelitis by Food and Gut Microbiota. Front Immunol (2017) 0.75
Similarities and differences in combined toxicity of sulfonamides and other antibiotics towards bacteria for environmental risk assessment. Environ Monit Assess (2016) 0.75
Diversity of the human intestinal microbial flora. Science (2005) 49.64
An obesity-associated gut microbiome with increased capacity for energy harvest. Nature (2006) 44.35
Metagenomic analysis of the human distal gut microbiome. Science (2006) 29.76
Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell (2004) 29.32
The human microbiome project. Nature (2007) 28.53
Host-bacterial mutualism in the human intestine. Science (2005) 26.39
Development of the human infant intestinal microbiota. PLoS Biol (2007) 18.91
Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell (2006) 18.83
The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol (2008) 16.57
Commensal host-bacterial relationships in the gut. Science (2001) 14.82
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A (2008) 14.18
Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr (1995) 13.30
A microbial symbiosis factor prevents intestinal inflammatory disease. Nature (2008) 13.15
Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature (2008) 12.45
Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut (2005) 10.95
Exploring microbial diversity and taxonomy using SSU rRNA hypervariable tag sequencing. PLoS Genet (2008) 10.72
Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A (2002) 9.78
Microbial influences in inflammatory bowel diseases. Gastroenterology (2008) 9.20
ATP drives lamina propria T(H)17 cell differentiation. Nature (2008) 8.02
The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med (2000) 7.78
Probiotics in man and animals. J Appl Bacteriol (1989) 7.43
Clinical practice. Antibiotic-associated diarrhea. N Engl J Med (2002) 7.13
Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol (2002) 6.74
Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A (2008) 6.42
Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ (2007) 5.99
Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol (2003) 5.87
Bacteriocins: developing innate immunity for food. Nat Rev Microbiol (2005) 5.77
Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology (2005) 5.75
Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol (2000) 5.72
Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Gastroenterology (2007) 5.40
Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science (2000) 5.38
Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ (2002) 5.36
IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe (2007) 5.18
Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology (1999) 5.03
Microbiology in the post-genomic era. Nat Rev Microbiol (2008) 4.88
Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity (2007) 4.87
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology (2003) 4.40
High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut (2008) 4.10
Necrotising enterocolitis. Lancet (2006) 3.94
Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol (2003) 3.84
Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol (2002) 3.79
Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun (2008) 3.68
Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci U S A (2007) 3.32
The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med (2006) 3.30
Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr (2005) 3.26
Enteric infections, diarrhea, and their impact on function and development. J Clin Invest (2008) 3.23
Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ (2007) 3.02
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut (2004) 3.01
Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet (2003) 2.92
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol (2005) 2.90
Malnutrition as an enteric infectious disease with long-term effects on child development. Nutr Rev (2008) 2.84
Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev (2004) 2.70
Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine. J Exp Med (2008) 2.63
Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther (2007) 2.61
Gut microbiota: a potential new territory for drug targeting. Nat Rev Drug Discov (2008) 2.59
An antibiotic-responsive mouse model of fulminant ulcerative colitis. PLoS Med (2008) 2.50
A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol (2006) 2.45
Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut (2003) 2.37
Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol (2007) 2.33
Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut (2004) 2.29
The Bacillus subtilis quorum-sensing molecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transporter. Cell Host Microbe (2007) 2.26
Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med (2006) 2.16
Roseburia intestinalis sp. nov., a novel saccharolytic, butyrate-producing bacterium from human faeces. Int J Syst Evol Microbiol (2002) 2.14
Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol (2004) 2.13
Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics (2007) 2.10
Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut (2000) 2.07
Bacterial imprinting of the neonatal immune system: lessons from maternal cells? Pediatrics (2007) 2.07
Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials. Dis Colon Rectum (2008) 2.04
Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther (1992) 1.99
Reduced serum amino acid concentrations in infants with necrotizing enterocolitis. J Pediatr (2000) 1.97
Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet (2007) 1.96
Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev (2008) 1.93
Antibiotics increase functional abdominal symptoms. Am J Gastroenterol (2002) 1.92
Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am J Physiol Gastrointest Liver Physiol (2007) 1.91
Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol (2008) 1.83
Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr (1997) 1.80
Development of bacterial and bifidobacterial communities in feces of newborn babies. Anaerobe (2003) 1.78
Cesarean delivery may affect the early biodiversity of intestinal bacteria. J Nutr (2008) 1.78
Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflamm Bowel Dis (2008) 1.77
Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics (2008) 1.74
Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm Bowel Dis (2002) 1.70
A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol (2006) 1.67
Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse. J Proteome Res (2008) 1.67
Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol (2006) 1.66
IL-23/IL-17 immunity as a hallmark of Crohn's disease. Inflamm Bowel Dis (2008) 1.66
A recombinant probiotic for treatment and prevention of cholera. Gastroenterology (2006) 1.64
Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii. Ann Pharmacother (2007) 1.64
Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut (2005) 1.63
Host-bacterial coevolution and the search for new drug targets. Curr Opin Chem Biol (2008) 1.63
Review article: prebiotics in the gastrointestinal tract. Aliment Pharmacol Ther (2006) 1.59
Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis (2008) 1.57
Salivary mutans streptococci and lactobacilli levels after ingestion of the probiotic bacterium Lactobacillus reuteri ATCC 55730 by straws or tablets. Acta Odontol Scand (2006) 1.54
Immunomodulatory effects of probiotics in the intestinal tract. Curr Issues Mol Biol (2008) 1.54
Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect (2006) 1.52
Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. J Antimicrob Chemother (1999) 1.52
Probiotics affect virulence-related gene expression in Escherichia coli O157:H7. Appl Environ Microbiol (2007) 1.51
Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile. Microb Ecol (2008) 1.51
Commensal Gram-negative bacteria prime human dendritic cells for enhanced IL-23 and IL-27 expression and enhanced Th1 development. Eur J Immunol (2004) 1.50
Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis (2005) 3.91
Clinical laboratory reports in molecular pathology. Arch Pathol Lab Med (2007) 3.55
Microbial DNA typing by automated repetitive-sequence-based PCR. J Clin Microbiol (2005) 3.44
Metagenomic pyrosequencing and microbial identification. Clin Chem (2009) 2.81
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology (2011) 2.60
Human microbiome in health and disease. Annu Rev Pathol (2011) 2.18
The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. FASEB J (2012) 2.13
A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PLoS One (2012) 1.98
Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol (2006) 1.89
Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe (2012) 1.81
Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflamm Bowel Dis (2008) 1.77
The human microbiome and its potential importance to pediatrics. Pediatrics (2012) 1.74
Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol (2009) 1.62
Three-year surveillance of community onset health care-associated staphylococcus aureus infections in children. Pediatr Infect Dis J (2006) 1.60
Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005. J Clin Microbiol (2009) 1.55
Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS One (2012) 1.50
Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism. Cell Microbiol (2003) 1.50
Probiotics-host communication: Modulation of signaling pathways in the intestine. Gut Microbes (2011) 1.38
Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice. Infect Immun (2005) 1.37
Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap Adv Gastroenterol (2013) 1.35
Widespread outbreak of norovirus gastroenteritis among evacuees of Hurricane Katrina residing in a large "megashelter" in Houston, Texas: lessons learned for prevention. Clin Infect Dis (2007) 1.34
Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe (2008) 1.30
Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modulation of NF-kappaB and MAPK signalling. Cell Microbiol (2008) 1.30
Molecular assays in the diagnosis of neonatal sepsis: a systematic review and meta-analysis. Pediatrics (2011) 1.30
DNA pyrosequencing-based bacterial pathogen identification in a pediatric hospital setting. J Clin Microbiol (2007) 1.30
Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods. Curr Opin Biotechnol (2009) 1.28
Exploring metabolic pathway reconstruction and genome-wide expression profiling in Lactobacillus reuteri to define functional probiotic features. PLoS One (2011) 1.25
Differences in laboratory findings for cerebrospinal fluid specimens obtained from patients with meningitis or encephalitis due to herpes simplex virus (HSV) documented by detection of HSV DNA. Clin Infect Dis (2002) 1.23
DNA pyrosequencing-based identification of pathogenic Candida species by using the internal transcribed spacer 2 region. Arch Pathol Lab Med (2008) 1.23
Genomic and genetic characterization of the bile stress response of probiotic Lactobacillus reuteri ATCC 55730. Appl Environ Microbiol (2008) 1.23
Probiotics, enteric and diarrheal diseases, and global health. Gastroenterology (2010) 1.16
The early response to acid shock in Lactobacillus reuteri involves the ClpL chaperone and a putative cell wall-altering esterase. Appl Environ Microbiol (2007) 1.15
The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes (2012) 1.12
Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates. Antimicrob Agents Chemother (2008) 1.11
Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine. FASEB J (2012) 1.10
Ethical, legal, and social considerations in conducting the Human Microbiome Project. Genome Res (2008) 1.10
The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin Chem (2013) 1.07
The Genboree Microbiome Toolset and the analysis of 16S rRNA microbial sequences. BMC Bioinformatics (2012) 1.05
Colonic mucosal DNA methylation, immune response, and microbiome patterns in Toll-like receptor 2-knockout mice. FASEB J (2011) 1.05
Hospital-acquired Staphylococcus aureus infections at Texas Children's Hospital, 2001-2007. Infect Control Hosp Epidemiol (2010) 1.02
Rapid stool-based diagnosis of Clostridium difficile infection by real-time PCR in a children's hospital. J Clin Microbiol (2011) 1.01
Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial. Ann Surg (2005) 1.00
How can probiotics and prebiotics impact mucosal immunity? Gut Microbes (2010) 0.98
Probiotics and gastrointestinal infections. Interdiscip Perspect Infect Dis (2009) 0.96
Perspectives on human microbiome research ethics. J Empir Res Hum Res Ethics (2012) 0.95
Lactobacillus reuteri strain combination in Helicobacter pylori infection: a randomized, double-blind, placebo-controlled study. J Clin Gastroenterol (2014) 0.94
Significant morbidity and mortality attributable to rothia mucilaginosa infections in children with hematological malignancies or following hematopoietic stem cell transplantation. Pediatr Hematol Oncol (2013) 0.94
Lactobacillus saerimneri and Lactobacillus ruminis: novel human-derived probiotic strains with immunomodulatory activities. FEMS Microbiol Lett (2009) 0.93
Novel synergistic antibiofilm combinations for salvage of infected catheters. J Med Microbiol (2009) 0.93
Host response to probiotics determined by nutritional status of rotavirus-infected neonatal mice. J Pediatr Gastroenterol Nutr (2012) 0.93
HIV update. Diagnostic tests and markers of disease progression and response to therapy. Am J Clin Pathol (2002) 0.90
Cyclopropane fatty acid synthase mutants of probiotic human-derived Lactobacillus reuteri are defective in TNF inhibition. Gut Microbes (2011) 0.87
Functional identification in Lactobacillus reuteri of a PocR-like transcription factor regulating glycerol utilization and vitamin B12 synthesis. Microb Cell Fact (2011) 0.86
mtDNA haplogroup and single nucleotide polymorphisms structure human microbiome communities. BMC Genomics (2014) 0.86
Probiotics: intestinal gatekeeping, immunomodulation, and hepatic injury. Hepatology (2007) 0.86
Cellulose supplementation early in life ameliorates colitis in adult mice. PLoS One (2013) 0.86
Farnesol decreases biofilms of Staphylococcus epidermidis and exhibits synergy with nafcillin and vancomycin. Pediatr Res (2011) 0.86
Molecular microbiological methods in the diagnosis of neonatal sepsis. Expert Rev Anti Infect Ther (2010) 0.86
Lactobacillus reuteri promotes Helicobacter hepaticus-associated typhlocolitis in gnotobiotic B6.129P2-IL-10(tm1Cgn) (IL-10(-/-) ) mice. Immunology (2011) 0.86
Biofilm extracellular DNA enhances mixed species biofilms of Staphylococcus epidermidis and Candida albicans. BMC Microbiol (2013) 0.85
Helicobacter hepaticus catalase shares surface-predicted epitopes with mammalian catalases. Microbiology (2007) 0.84
Burkholderia gladioli osteomyelitis in association with chronic granulomatous disease: case report and review. Pediatr Infect Dis J (2005) 0.84
Anti-inflammatory properties of gastric-derived Lactobacillus plantarum XB7 in the context of Helicobacter pylori infection. Helicobacter (2014) 0.83
Polymicrobial bloodstream infections in the neonatal intensive care unit are associated with increased mortality: a case-control study. BMC Infect Dis (2014) 0.83
Molecular epidemiological surveillance of multidrug-resistant Pseudomonas aeruginosa isolates in a pediatric population of patients with cystic fibrosis and determination of risk factors for infection with the Houston-1 strain. J Clin Microbiol (2013) 0.82
The human microbiome and probiotics: implications for pediatrics. Curr Probl Pediatr Adolesc Health Care (2008) 0.82
Is real-time detection of drug-resistant Staphylococcus aureus worth considering? Arch Pathol Lab Med (2003) 0.81
Probiotic prophylaxis in predicted severe acute pancreatitis. Lancet (2008) 0.80
Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cells. BMC Microbiol (2014) 0.79
Fur-independent induction of Helicobacter pylori flavodoxin-encoding gene (fldA) under iron starvation. Helicobacter (2009) 0.77
National Institutes of Health Gastrointestinal Microbiota and Advances in Prebiotic and Probiotic Research conference summary. Gastroenterology (2009) 0.77
Expanding the diagnostic capabilities of molecular microbiology by genomic methods. J Mol Diagn (2007) 0.75
Helicobacter hepaticus cholesterol-α-glucosyltransferase is essential for establishing colonization in male A/JCr mice. Helicobacter (2014) 0.75
Infectious diseases testing. Curr Protoc Hum Genet (2005) 0.75
An unusual cause of sepsis and meningitis in a neonate. Semin Pediatr Infect Dis (2006) 0.75